Clinical Trials Browser

Phase 2 × Appendiceal Neoplasms × nintedanib × Clear all

NCT03287947 2022-08-09

LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma

Phase 2 Terminated

5 enrolled 12 charts

Gastrointestinal

Appendiceal Neoplasms